Amrutanjan Health Care Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2025, declared Select Dividend of Rs. 2.60 per equity share.
AMRUTANJAN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amrutanjan Health Care's board approved audited results for Q4 and FY25 (ended March 31, 2025). Full-year revenue from operations rose to Rs. 45,181.63 lakhs (from Rs. 42,123.05 lakhs, up ~7.3%), while profit after tax grew to Rs. 5,083.47 lakhs (from Rs. 4,497.26 lakhs, up ~13%), with EPS at Rs. 17.58 vs Rs. 15.50. The board recommended a final dividend of Rs. 2.60 per share, taking total FY25 dividend to Rs. 3.60 per share (including Rs. 1 interim already paid), subject to AGM approval. Operating cash flow more than doubled to Rs. 5,089.92 lakhs from Rs. 2,791.06 lakhs. Statutory auditor BSR & Co. LLP issued an unmodified (clean) opinion. Additionally, Company Secretary M Srinivasan will retire on May 31, 2025, and Gagan Preet Singh will take over from June 1, 2025.
Steady single-digit revenue growth and double-digit profit growth, a clean audit opinion, and consistent dividends are mildly positive for shareholders. The leadership change at the Company Secretary level is routine and unlikely to affect operations.